Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary int

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary int

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Heart Journal - Volume 149, Issue 3, March 2005, Pages 402-407

Paul W. MD, Peter X. MD, Hussein R. PhD, Christian MD, David MD, William MD, Thomas G. MD, Alec MD, Frans MD, Christopher B. MD, on behalf of the APEX-AMI Steering Committee on behalf of the APEX-AMI Steering Committee,